Swiss Pharmaceuticals & Biotech Profitable Climbers

SKAN Group

Market Cap: CHF 1.1b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Kuros Biosciences

Market Cap: CHF 737.3m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Dottikon ES Holding

Market Cap: CHF 4.2b

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia.

Galderma Group

Market Cap: CHF 38.6b

Operates as a dermatology company worldwide.